Unknown PHASE1 INTERVENTIONAL 3-arm NCT02494609

Oral Contraceptive DDI Study

A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and Ortho-Cyclen®, an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women

Sponsor: Lexicon Pharmaceuticals

Conditions Healthy

Interventions oral contraceptive oral contraceptive + sotagliflozin sotagliflozin

Updated 7 times since 2017 Last updated: Feb 29, 2016 Started: Jul 31, 2015 Primary completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is ongoing. The trial is conducted by Lexicon Pharmaceuticals and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Mar 2018 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Mar 2018 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lexicon Pharmaceuticals

Data source: Lexicon Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States
• Evansville, United States